Buy the full study
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market Overview
1.1 Definition and presentation
Medical biology laboratories (LBMs), formerly known as medical analysis laboratories (MLAs), are places whose function is to perform medical diagnosis and monitoring based on samples of various human biological fluids. They are run by biologists.
The market for medical biology laboratories can be segmented according to the presence or absence of certification, inspection, testing and accreditation of the laboratories themselves.
In 2024 the world market for clinical testing laboratories is estimated at 277.$96 billion. Moderate growth in the industry is expected in the near future. For the period 2024-2029 a compound annual growth rate is estimated (CAGR) of 6.49 percent, under which the market could reach a total value of more than 380 billion dollars.
In Italy there are about 37,870 people working within the nearly 10,000 laboratories in the territory.
The difference between accredited and non-accredited laboratories also falls in turnover. The growth rate of turnover is much higher in accredited entities. In addition, accredited laboratories are considered much more efficient and with higher labor productivity.
it is important to consider the positive contribution that the medical biology laboratory industry makes to the development of the National Health Service. This industry has significant rates of investment in research and innovation, which are fundamental to the development of Italy's healthcare and economy.
The largest biomedical center can be found in Mirandola (Emilia Romagna). Northern Italy is in general the area where companies and turnover in this market are most concentrated. In Central Italy, most of the laboratories are concentrated in Lazio and Tuscany, while as far as Southern Italy is concerned we notice a smaller presence in general except for Campania, Puglia and Sicily.
This type of industry is extremely important at the healthcare level, and this was also demonstrated by the recent Covid-19 pandemic, which exposed all the flaws in the system and reiterated how necessary it is to invest in research and scientific innovation in order to increase the speed and accuracy of the medical tests that these laboratories perform.
1.2 The Global Market
In ****, the world market for clinical testing laboratories is estimated at $***.** billion. Moderate growth in the industry is expected in the near future. A compound annual growth rate (***) of *.**% is estimated for the period ****-****, under which the market could reach a total value of more than $*** billion by the end ...
1.3 The Italian Market
A total of *,*** outpatient/laboratory type health facilities were surveyed in Italy in ****: *,*** facilities are public while *,*** are private facilities accredited to the National Health System. As a result, there are an estimated *.* public laboratories per ***,*** inhabitants and *.* accredited private laboratories per ***,*** inhabitants. In terms of laboratories alone, in **** there are ...
1.4 Impact of Covid
Testing laboratories have been at the center of the global pandemic. it is clear that they have not been overly affected by the crisis, benefiting from both the continuity of business even during containment and the increased demand for Covid-** testing.
There are several testing laboratories that, indeed, saw their revenues ...
2 Demand analysis
2.1 The main drivers of demand
Several drivers can drive the demand for private clinics in Italy. We can find two main categories, demographic characteristics of the Italian population and income characteristics .
The age distribution andmedian age of the Italian population are also important factors to consider in order to better understand this market and its ...
2.2 Geographic Distribution of Demand
In total, the number of laboratory tests in Italy in **** was *.** billion, up **.*% from ****. Compared with the pre-pandemic period, the number of laboratory analyses performed increased by **.*% (***).
Number of clinical biological and chemical analyses, by year Italy, **** - ****, in millions of analyses Source: ****
Regarding the geographical distribution of analyses performed in ...
3 Market structure
3.1 Market Structure
In order to analyze the structure of the laboratory market, active enterprises under Ateco Code **.**.* "Clinical analysis laboratories, X-ray laboratories and other diagnostic imaging centers" are analyzed. In particular, trends in the number of active enterprises and the number of employees as well as the legal form of different activities are ...
3.2 The main actors
A list of the main players active in the medical biology laboratory sector is proposed below:
Synlab Italia s.r.l: founded in ****, represents one of the main players in the medical testing and diagnostic services sector in Italy. Part of the Synlab Group, a European leader in medical diagnostics, the ...
3.3 Geographic Distribution
Regarding the geographic distribution of medical biology laboratories, in **** Campania, Lazio, and Sicily top the national ranking with a total of ***, ***, and *** laboratories, respectively. They are followed by Puglia (***).
4 Supply analysis
4.1 Breakdown of medical biology expenses by pathology
Nearly **% of laboratory expenses are general expenses not related to a specific disease. These are routine care, analgesic treatments, occasional hospitalizations, etc. As for the rest of the expenditures, cardiovascular disease and cancer are the largest items with *.*% and *.*% of total expenditures, respectively.
These observations are logical, since the focus of ...
4.2 The different types of Laboratories
Two types of laboratories can be distinguished in the market:
Routine biology laboratories
Nonspecialized laboratories are the most prevalent in the area. Their role is to meet the classic demand for medical analysis. These laboratories are often clustered around technical platforms. A place that collects equipment shared by different health institutions, ...
5 Regulations
5.1 Regulation
In Paragraph ***, Article * of Law No. ***/****, Finance Act ****, laboratory medicine activities are defined as follows : The activity of laboratory medicine provides information obtained by chemical, physical or biological methods on tissues or fluids of human origin or on materials related to human pathology, for the purpose of prevention, diagnosis, monitoring of ...
6 Positioning of actors
6.1 Segmentation
- Synlab Italia s.r.l
- C.D.C s.p.a
- Bianalisi s.p.a
- Unione Sanitaria Internazionale s.p.a
- Eurofins Genoma Group s.r.l
- Synlab Sdn s.r.l
List of charts presented in this market study
- Allocation of Clinical Laboratories between Private and Public
- Trends in the Financing of the National Health System
- Health Expenditure of EU Countries
- Clinical testing laboratory market
- Breakdown of the population
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Synlab strengthens in Tuscany: 8 mln and 80 new jobs - 28/06/2023
- Synlab's turnover: 3.8 billion.
- Synlab's presence: 36 countries.
- New Medical Center in Florence: about 4,000 square meters.
- New jobs offered: about 80.
- Diagnostic and medical services for: 200,000 patients per year.
- Investment in equipment and facilities: 8 million euros.
- Number of outpatient clinics in the center: more than 40.
- Dedicated plan for advanced diagnostic imaging: Yes.
- Other Relevant Information:
- The Center will offer a wide range of diagnostic services, including examinations in genetics, oncology, and pathological anatomy.
- There will be a first area dedicated to women's health and prevention created in a Synlab facility in Tuscany.
- The Manifattura Tabacchi project focuses on reducing environmental impacts and greenhouse gas emissions by maximizing energy and water savings.
- The Synlab Medical Center will be located in the Bulk, an eco-friendly building designed by Piuarch Studio.
SYNLAB appoints Andrea Buratti as new Italy CEO - 06/06/2023
- Appointment of Andrea Buratti as the new CEO of SYNLAB Italy: This change in leadership may signal a potential strategic or operational renewal within the company, which could affect its position in the market.
- Andrea Buratti's experience and background: With a background in management engineering and a decade of experience in management consulting, followed by significant roles in healthcare and laboratory diagnostics, Buratti brings a wealth of experience to SYNLAB. His professional history suggests expertise in business growth, innovation and strategic management, factors relevant to assessing SYNLAB's future development.
- Goals and directions of the new CEO: Buratti's emphasis on innovation, scientific research, medical excellence, and customer focus provides insights into the strategic elements that could guide SYNLAB in the coming years. These pillars can have an impact on the company's market share and competitiveness.
- Buratti's previous professional roles: His experience as CFO, Deputy Country Manager and Chief Commercial Officer suggests a strong ability to manage financial, operational and commercial aspects of an organization, which are crucial for success in the competitive medical diagnostics market.
- Buratti's professional affiliations: His role as President of ANISAP Lombardy and member of the Healthcare group of Assolombarda and Confindustria Lombardia indicates a deep commitment and good network in the regional healthcare sector and business scenario, which could foster further developments and collaborations for SYNLAB.
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the medical biology laboratory market | Italy
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
5 reports pack (-15%) IT Italy
- 5 reports at €75.6 excluding VAT per study to choose from our Italian catalogue for 12 months
- Save 15% on additional studies purchased
- Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)
See the terms and conditions of the pack and the refund of unused credit.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
